Evidence map›Paper›PMID 42238574›Full record

ArticleFrontiers in immunology2026

Evaluation of kidney stone-related renal infection status by 18F-FDG PET/CT in lung cancer patients with concomitant nephrolithiasis: a multicenter study.

Xiangyang Yao, Xiaolong Ying, Hua Liu, Chen Duan, Bo Li, Zongyao Hao, Zhangqun Ye, Hua Xu, Hongbing Mei, Haoran Liu and 1 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiangyang Yao *Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Xiaolong Ying *Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Hua Liu *Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Chen DuanDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Bo LiDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zongyao HaoDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhangqun YeDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hua XuDepartment of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Hongbing MeiDepartment of Urology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Haoran LiuDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jianhe LiuDepartment of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Positron emission tomography/computed tomography (PET/CT) has demonstrated significant clinical utility in the localization of infectious foci, yet its application in nephrolithiasis-associated renal infections remains underexplored. Methods: This retrospective cohort study assessed the diagnostic efficacy of Results: Clinically, PET/CT detected focal FDG uptake in 77 patients (64.2%), demonstrating 85.7% sensitivity and 76.7% specificity for infection identification. SUVmax positively correlated with stone burden and proinflammatory cytokines. The larger the size of the stone, the more severe the kidney infection, which in turn further aggravated the development of the stone. Furthermore, preclinical micro-PET/CT in CaOx mice revealed spatial concordance between crystal deposition and metabolic activity, paralleling human cytokine trends. Discussion: In lung cancer patients with concomitant nephrolithiasis,

Indexed as

Fluorodeoxyglucose F18Kidney CalculiLung NeoplasmsNephrolithiasisPositron Emission Tomography Computed TomographyAdultAgedAnimalsFemaleHumansMaleMiceMiddle AgedRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18RadiopharmaceuticalsCaOxkidney stonenephrocalcinosisPET/CTrenal infection

Identifiers

PMID42238574
PMCPMC13226474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.